van Besien K, Hoffman R, Golichowski A
Division of Hematology/Oncology, Indiana University Hospitals, Indianapolis 46202-5121.
Thromb Res. 1991 Apr;62(1-2):23-9. doi: 10.1016/0049-3848(91)90665-j.
The management of pregnant patients with coagulopathies and heparin induced thrombocytopenia is difficult and poorly defined. We report the case of a patient who was treated with a low molecular weight heparinoid. The treatment was complicated by the delayed occurrence of thrombocytopenia and a thrombotic event. This is the first report of thrombocytopenia caused by heparinoid. It is possible that this complication could have been avoided by a shorter duration of treatment with heparinoid and the use of Vitamin K antagonists during the second trimester of pregnancy.